Postal survey of physicians and laboratories: Practices and perceptions of molecular oncology testing

BMC Health Services Research

Volumn 9, Issue , 2009, Pages

  Miller, Fiona A ^a   Krueger, Paul ^b   Christensen, Robert J ^a   Ahern, Catherine ^a   Carter, Ronald F ^c   Kamel Reid, Suzanne ^b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANADA; CLINICAL LABORATORY; CONTINUING EDUCATION; FUNDING; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; LABORATORY TEST; MOLECULAR GENETICS; MOLECULAR ONCOLOGY TESTING; ONCOLOGY; PATIENT REFERRAL; PHYSICIAN ATTITUDE; POSTAL MAIL; ATTITUDE; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; GENETIC PROCEDURES; GENETIC SCREENING; GENETICS; LABORATORY; MALE; MASS SCREENING; METHODOLOGY; NEOPLASM; PATHOLOGY; PHYSICIAN; UTILIZATION REVIEW;

ATTITUDE; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC SCREENING; GENETIC TECHNIQUES; HEALTH CARE SURVEYS; HUMANS; LABORATORIES; MALE; MASS SCREENING; NEOPLASMS; ONTARIO; PATHOLOGY, CLINICAL; PHYSICIANS;

EID: 69449107418     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-9-131     Document Type: Article

References (31)

1. A health services research agenda for cellular, molecular and genomic technologies in cancer care. L Wideroff K Phillips G Randhawa A Ambs K Armstrong C Bennett M Brown M Donaldson M Follen S Goldie RA Hiatt MJ Khoury G Lewis HL McLeod M Piper I Powell D Schrag KA Schulman J Scott, Public Health Genomics 2009 12 4 233 244
2. Personalized medicine and development of targeted therapies: the upcoming challenge for diagnostic molecular pathology. M Dietel C Sers, Virchows Arch 2006 448 744 755
3. Genomics and proteomics: Emerging technologies in clinical cancer research. CH Chung S Levy P Chaurand DP Carbone, Crit Rev Oncol Hematol 2007 61 1 25
4. Genomic biomarkers for cancer assessment: implementation challenges for laboratory practice. KH Pritzker A Azad, Clin Biochem 2004 37 642 64615234245
5. Realizing the promise of personalized medicine. MG Aspinall RG Hamermesh, Harv Bus Rev 2007 R0710F
6. Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges. P Deverka T Doksum R Carlson, Clin Pharmacol Ther 2007 82 4 427 434
7. Towards a molecular classification of hematolymphoid neoplasms: where are we now? Where are we going? E Hsi, J Histochem Cytochem 2001 49 10 1323 1324
8. Glioma classification: a molecular reappraisal. D Louis E Holland J Cairncross, Am J Pathol 2001 159 3 779 786
9. Current status of prognostic profiling in breast cancer. L Pusztai, Oncologist 2008 13 4 350 360 (Pubitemid 351679913)
10. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management. D Malinowski, Expert Rev Mol Diagn. 2007 7 3 269 280 (Pubitemid 46798617)
11. Trastuzumab for the adjuvant treatment of early-stageHER2-positive breast cancer. National Institute for Health and Clinical Excellence (NICE), Technology appraisal guidance 2006 http://www.guideline.gov/summary/summary. aspx?doc-id=10956&nbr=5736&ss=6&xl=999 No.107
12. The impact of molecular diagnostic tests on patient outcomes. JS Ross, Clinics In Laboratory Medicine 1999 19 4 815 831
13. The integration of molecular diagnostics with therapeutics. JS Ross GS Ginsburg, Am J Clin Pathol. 2003 119 1 26 36
14. Oncogene addiction. IB Weinstein A Joe, Cancer Research 2008 68 9 3077 3080
15. Genomics and proteomics in predicting cancer outcomes. AA Parikh JC Johnson NB Merchant, Surg Oncol Clin N Am 2008 17 257 277
16. Panitumubab, Recommendations and Reasons. Committee to Evaluate Drugs (CE), Ontario Ministry of Health and Long-Term Care, Ontario Public Drug Programs 2009 http://www.health.gov.on.ca/english/providers/program/drugs/ced/ pdf/vectibix.pdf
17. EuroGentest: DNA-based testing for heritable disorders in Europe. P Javaher H Kaariainen U Kristoffersson I Nippert J Sequeiros R Zimmern J Schmidtke, Community Genetics 2008 11 2 75 120
18. Genetic services for hereditary breast/ovarian and colorectal cancers: physicians' awareness and satisfaction. JC Carroll M Cappelli FA Miller B Wilson E Grunfeld C Peeters A Hunter C Gilpen P Prakash, Community Genetics 2008 11 43 51
19. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. L Wideroff S Vadaparampil M Greene S Taplin L Olson A Freedman, J Med Genet 2005 42 749 755
20. Quality Assurance in Molecular Genetic Testing Laboratories. MM McGovern MO Benach S Wallenstein RJ Desnick R Keenlyside, JAMA 1999 281 9 835 840
21. Molecular genetic testing in the United States: Comparison with international practice. M McGovern R Elles E Ronchi J Boone IM Lubin, Genetic Testing 2008 12 2 187 193
22. Genetic Testing: A Survey of Quality Assurance and Proficiency Standards. Organisation for Economic Cooperation and Development, Paris: OECD 2007 http://www.oecd.org/document/55/0,3343,en-2649-34537-39531255-1-1-1-1,00. html#HTO
23. Request for public comment on a proposed classification methodology for determining level of review for genetic tests, Department of Health and Human Services. Secretary's Advisory Committee on Genetic Testing, Federal Register 2000 65 236 78843 78845 http://oba.od.nih.gov/oba/sacgt/frnotices/GTFR120700.pdf
24. Molecular Medicine: How, what, and when. J Woodcock, Clin Pharmacol Ther. 2007 82 4 376 378
25. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? M Khoury M Gwinn P Yoon N Dowling C Moore L Bradley, Genet Med 2007 9 10 665 675
26. D Dillman, Mail and Internet surveys: The tailored design method New York: John Wiley Second edition 2000
27. Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer a plan to move forward. G Kelloff S Lippman A Dannenberg C Sigman H Pearce B Reid E Szabo V Jordan M Spitz G Mills, Clinical Cancer Research 2006 12 12 3661 3697
28. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma. SJ Richards AS Jack, Clinical and Laboratory Haematology 2003 25 6 337 342
29. Ensuring access tohigh quality molecular oncology laboratory testing and clinicalcancer genetic services in Ontario. Molecular Oncology Task Force CCO, Report of the MolecularOncology Task Force 2008 http://www.cancercare.on.ca/ common/pages/UserFile.aspx?fileId=31935
30. New directions in laboratory-clinician communications. O Zinder, Clin Chim Acta. 1998 278 2 83 94
31. The clinical importance of laboratory reasoning. M Plebani, Clin Chim Acta. 1999 280 1-2 35 45